{"entity":{"id":"galderma","kind":"company","name":"Galderma","aka":["Galderma R&D","Galderma S.A."],"tldr":"Galderma is a Swiss dermatology company, listed in 2024, whose cancer-related trials concern photodynamic therapy for actinic keratosis and basal cell carcinoma.","summary":"Galderma, based in Zug and listed on the SIX Swiss Exchange since 2024, is a dermatology company spanning prescription medicines, aesthetics and consumer skin care. Its cancer-related registry trials mostly concern methyl aminolevulinate photodynamic therapy (Metvix) for actinic keratosis and superficial basal cell carcinoma. OnCo records it so that those phase 3 trials resolve to a sponsor page.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.galderma.com"},{"label":"ClinicalTrials.gov: trials led by Galderma","url":"https://clinicaltrials.gov/search?lead=Galderma"},{"label":"Wikipedia","url":"https://en.wikipedia.org/wiki/Galderma"}],"tags":["ctgov-sponsor"],"related":[],"cancers":["basal-cell-carcinoma","cutaneous-scc"],"sections":["prevention"],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Zug","country":"CH","companyType":"pharma","website":"https://www.galderma.com","stage":"public","investors":[],"funding":[]},"route":"/companies/galderma/","neighbours":{"cancer":[{"id":"basal-cell-carcinoma","kind":"cancer","name":"Basal cell carcinoma","route":"/cancers/basal-cell-carcinoma/"},{"id":"cutaneous-scc","kind":"cancer","name":"Cutaneous squamous cell carcinoma","route":"/cancers/cutaneous-scc/"}],"section":[{"id":"prevention","kind":"section","name":"Prevention & Risk","route":"/fronts/prevention/"}]}}